Show simple item record

dc.contributor.authorAtalell, K.A.
dc.contributor.authorAlene, Kefyalew
dc.date.accessioned2021-11-17T09:43:34Z
dc.date.available2021-11-17T09:43:34Z
dc.date.issued2020
dc.identifier.citationAtalell, K.A. and Alene, K.A. 2020. Poor treatment outcomes of children on highly active antiretroviral therapy: Protocol for a systematic review and meta-analysis. BMJ Open. 10 (12): Article No. e040161.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/86486
dc.identifier.doi10.1136/bmjopen-2020-040161
dc.description.abstract

Introduction: While access to highly active antiretroviral therapy (HAART) for children with HIV has expanded and the use of HAART has substantially reduced the morbidity and mortality of children due to HIV, poor treatment outcomes among children with HIV are still a major public health problem globally. The aim of this systematic review and meta-analysis is to quantify treatment outcomes among children with HIV.

Methods and analysis: Systematic searches will be conducted in three electronic databases (PubMed, SCOPUS and Web of Science) for recent studies published from 01 Jan 2000 up to 28 October 2020, without geographical restriction. The primary outcomes of the study will be poor treatment outcomes, which include death, treatment failure and loss to follow-up. We will include quantitative studies that report treatment outcomes among children under the age of 18 years with HIV. Studies will be excluded if they are case report, case series, conducted among adults only or do not provide data on treatment outcomes for children. Two researchers will screen the titles and abstracts of all citations identified in our search, then review the full text of the remaining papers to identify those that meet the inclusion criteria. The Newcastle-Ottawa Scale will be used for quality assessment. A random-effects meta-analysis will be used to obtain pooled estimates of the proportion of poor treatment outcomes. The heterogeneity between studies will be checked visually by using forest plots and quantitatively measured by the index of heterogeneity (I2). Pooled estimates of poor treatment outcomes will be calculated with a random-effects model. Subgroup analysis will be conducted by study settings, treatment regimen, comorbidity (such as tuberculosis), study period and HIV type (HIV-1 and HIV-2).

Ethics and dissemination: Ethical approval will not be required for this study as it will be based on published papers. The final report of this review will be published in a peer-reviewed scientific journal.

dc.languageEnglish
dc.publisherBMJ PUBLISHING GROUP
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectScience & Technology
dc.subjectLife Sciences & Biomedicine
dc.subjectMedicine, General & Internal
dc.subjectGeneral & Internal Medicine
dc.subjectepidemiology
dc.subjectinfectious diseases
dc.subjectHIV &amp
dc.subjectAIDS
dc.subjectHIV-INFECTED CHILDREN
dc.subjectCLINICAL-OUTCOMES
dc.subjectIMPROVE
dc.subjectCARE
dc.titlePoor treatment outcomes of children on highly active antiretroviral therapy: Protocol for a systematic review and meta-analysis
dc.typeJournal Article
dcterms.source.volume10
dcterms.source.number12
dcterms.source.issn2044-6055
dcterms.source.titleBMJ Open
dc.date.updated2021-11-17T09:43:33Z
curtin.note

© Authors. This article has been accepted for publication in BMJ Open following peer review and can also be viewed on the journal’s website at http://dx.doi.org/10.1136/bmjopen-2020-040161.

curtin.departmentCurtin School of Population Health
curtin.accessStatusOpen access
curtin.facultyFaculty of Health Sciences
curtin.contributor.orcidAlene, Kefyalew [0000-0002-1904-4682]
curtin.contributor.researcheridAlene, Kefyalew [V-8240-2018]
curtin.identifier.article-numberARTN e040161
dcterms.source.eissn2044-6055
curtin.contributor.scopusauthoridAlene, Kefyalew [57202583764]


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/